A further recurrent event resulting in the constitutive activation of the NF-κB pathway in CLL is mutations in NFKBIE, which encodes IκBε and constitutes one of the negative regulators of the NF-κB pathway (54). Here, NFKBIE is linked to B-cell chronic lymphocytic leukemia.